Transforming IBD Care
Thank you to all our attendees, faculty, committee members, poster presenters, sponsors, exhibitors and partners for making the 2023 Crohn’s & Colitis Congress® a great success.
Transforming IBD Care
Join your colleagues from around the world and across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD). Don’t miss all the excitement!
The Crohn’s & Colitis Congress®, a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA), will take place virtually on January 20-22, 2022.
2022 Crohn's & Colitis Congress Goes Virtual
The Crohn’s & Colitis Foundation and AGA have cancelled in-person programming due to the challenges the coronavirus omicron variant outbreak places on the medical community. In order to have the safest and most educational meeting, all Crohn’s & Colitis Congress programming will be held virtually on January 20-22.
Speakers, moderators and poster presenters will receive more details by email later this week about your virtual participation.
Exhibitors will be contacted directly by a member of Congress management for further details.
Attendees: All registrations will be converted to virtual and housing reservations will be cancelled.
We look forward to a dynamic and educational virtual and on-demand experience. Thank you for your patience with this transition. We share our best wishes for your health and safety.
WE HOPE TO SEE YOU VIRTUALLY ON JANUARY 20–22, 2022.
Important Dates
Abstract Notifications: Monday, December 5, 2022
Advanced Registration Deadline: Wednesday, December 14, 2022
Important Dates
Registration
Registration Opens: Tuesday, September 27
Early Bird Registration Deadline: Wednesday, November 2
Advanced Registration Deadline: Friday, December 16
Abstract Submission
Abstract Submission Opened: Monday, September 12
Abstract Submission Deadline: Friday, October 21
Abstract Notifications: Monday, December 5
You can still register to join the live meeting. If you miss anything, the on-demand programming will be released on February 1, 2021, and be available for 90 days.
Why You Should Attend the Crohn’s & Colitis Congress
Drs. Jamie Kinnucan shares why she is excited to attend the Congress.
2023 Crohn's & Colitis Congress Chairs
Peter D. R. Higgins, MD, PhD, AGAF
Co-Chair, Organizing Committee
University of Michigan
Laura E. H. Raffals, MD, MS
Co-Chair, Organizing Committee
Mayo Clinic
Supporting Organizations
The 2023 Crohn’s & Colitis Congress was supported by an educational grant from:
Ferring Pharmaceuticals, Inc.
Lilly
Pfizer
Salix Pharmaceuticals, Inc.
Takeda Pharmaceuticals U.S.A., Inc.
Bristol Myers Squibb
Pfizer Inc.
Salix Pharmaceuticals, a division of Bausch Health US, LLC
Takeda Pharmaceuticals U.S.A., Inc.
Recognition
The 2023 Crohn’s & Colitis Congress was partnered with:
Media Partners
The 2023 Crohn’s & Colitis Congress was partnered with:
